Georgina Whetton, DOB 21 April 1954. Supporting data for GP review, 13 September 2026.

Hospital: Royal Stoke Hospital, University Hospitals of North Midlands NHS Trust. NHS number 454 282 0556. Assessment clinic appointment: 7 September 2026. Breast care nurse Sarah, direct line 01782 674077.

Medication record

This section shows which regular tablets were stopped on 22 August 2026, what is still taken every day, what is taken only when needed, and what has been taken occasionally over the past year.

Source: NHS repeat prescription printed 13 August 2026, annotated by the patient, and the NHS App record of a face to face medication review with the practice pharmacist, Mr Kasim Hussain, Alton Primary Care Centre, on 20 August 2026 at 11:10. The visible part of that note ends "explained sick day rules"; the remainder has not been seen. The patient's account, 10 September 2026: the tablets were dropped by agreement at that review, with a review in two months. The patient's message of 9 September 2026: "I stopped taking the above tablets on the marked x 22/08/26. Only taking omeprazole, betahistine and vitamins on a daily basis, the others as and when required."

Stopped 22 August 2026

Continuing daily

As required

Episodic in the last twelve months

Estradiol 10 microgram pessaries (December 2025, January 2026); naproxen 250 mg (September 2025); dexamethasone, neomycin and acetic acid ear spray (January 2026).

Other history from the patient's own account, 10 September 2026

Blood pressure

This section shows home blood pressure readings before and after the tablets above were stopped on 22 August 2026, taken with an arm cuff while sitting down. Readings from 160 systolic or above are marked in bold.

BP method confirmed by the patient, 10 September 2026: arm cuff, sitting down. Source: health app entries on the patient's phone, supplied 9 September 2026 (August to September 2026), and the Apple Health export of 12 February 2026 (earlier clusters). All are manual entries from a home cuff. No readings are on record between 12 February and 7 August 2026.

Summary by period

All readings, August and September 2026, oldest first

Glucose

This section shows fasting capillary (finger prick) blood glucose readings taken at home, before and after metformin was stopped on 22 August 2026, plus the HbA1c blood test trend from GP records.

Timing confirmed by the patient, 10 September 2026: taken mostly before breakfast, occasionally later if forgotten. Source: health app fasting capillary glucose entries, supplied 9 September 2026.

HbA1c (mmol/mol, range 20 to 41): approximately 55 (H) in 2023, approximately 48 (H) in 2024, 50 (H) on 11 April 2025, then approximately 37, approximately 36, and 36 across three samples taken between late 2025 and August 2026.

Cumulative results

The tables below list laboratory blood and urine results over several years, oldest to newest, against the laboratory's own reference range for each test. Reference ranges are the reporting laboratory's own. Blank cells mean not tested or not supplied. A figure shown with the symbol "approximately" was read from a trend chart in the NHS App rather than copied from an exact lab report, and is accurate to about one unit either way. "(H)" means the result was above the laboratory's normal range, and "(L)" means it was below it.

6.1 Renal profile and electrolytes

6.2 Full blood count

Laboratory comment on the August 2026 count: "05.12.2025: Please note updated reference range for Monocytes. Please note this assay is not currently UKAS accredited, pending assessment."

6.3 Iron

6.4 Liver function

Earlier ALT on the chart: approximately 58 in October 2023.

6.5 Lipids

All May 2026 lipids were taken on simvastatin 40 mg.

6.6 Diabetes

6.7 Thyroid

6.8 Urine

6.9 Not seen in any 2026 result

GGT, a date-stamped HbA1c value, neutrophil count: these are not seen anywhere in the 2026 laboratory results supplied.

Body composition, fitness and other history

This section brings together body composition scan data, smartwatch health data, one x-ray finding, and the patient's own list of long-standing symptoms.

Body composition (Tanita scans)

29 July 2026 against 23 February 2026: weight 66.2 kg (62.0 kg), body fat 32.4% (28.9%), fat mass 21.4 kg (17.9 kg), muscle mass 42.5 kg (41.8 kg, the highest of seven scans), BMI 26.8 (25.1), visceral fat rating 7 (6), bone mass 2.3 kg, BMR 1,322 kcal. Peak weight 81.0 kg in July 2025.

Apple Watch data to 12 February 2026

Eleven ECG recordings June to December 2025, all sinus rhythm; resting heart rate 67 (63 in mid-2025); heart rate variability 23.6 ms; VO2 max estimate 24.6; six-minute walk 463 m (peak 500 m in October 2025); walking steadiness 65 to 73%; walking asymmetry up to 17.6% in January 2026; average sleep 5.6 to 6.0 hours.

Imaging on record

Right shoulder x-ray, 9 February 2026: mild to moderate acromioclavicular joint degeneration, glenohumeral joint preserved, no calcific tendinopathy, incidental calcified granulomas in the right lung.

Self-reported history (June 2025 symptom list)

Arthritis in multiple joints, progressive; significant hair loss over six years, attributed by her to medication; contact dermatitis; recurrent respiratory infections; slow wound healing with monthly finger splits; chronic fatigue; gastro-oesophageal reflux disease; constipation; frequent headaches; vertigo; uterine prolapse; snoring and suspected sleep apnoea; haemorrhoids; allergic rhinitis.